Pohlmann, Adriana Raffin
Universidade Federal do Rio Grande do Sul,
Brazil
2025 Rank: 233796
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1833 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 233796 | 243795 |
| Total Cites | 914 | 1004 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 24 | 27 |
| Number of Single+First+Last Authored Papers | 83 | 83 |
| Total Cites to Single+First+Last Authored Papers | 152 | 171 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 746 | 773 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.30 |
| Self-Citation Percentage |
8.96%
|
|
Pohlmann, Adriana Raffin
Universidade Federal do Rio Grande do Sul,
Brazil
2023 Rank: 205393
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1578 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 205393 | 214069 |
| Total Cites | 865 | 972 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 30 | 32 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 148 | 178 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 684 | 709 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.37 |
| Self-Citation Percentage |
11.01%
|
|
Pohlmann, Adriana Raffin
Universidade Federal do Rio Grande do Sul,
Brazil
2021 Rank: 190878
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1469 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 190878 | 151372 |
| Total Cites | 1295 | 1684 |
| H-index | 15 | 17 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 33 | 47 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 262 | 389 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 977 | 1057 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.59 |
| Self-Citation Percentage |
23.10%
|
|
Pohlmann, Adriana Raffin
Universidade Federal do Rio Grande do Sul,
Brazil
2020 Rank: 234851
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1683 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 234851 | 187698 |
| Total Cites | 822 | 1082 |
| H-index | 11 | 13 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 16 | 26 |
| Number of Single+First+Last Authored Papers | 69 | 69 |
| Total Cites to Single+First+Last Authored Papers | 196 | 272 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 593 | 647 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.67 |
| Self-Citation Percentage |
24.03%
|
|